CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children's Hospital Medical Center (CCHMC) Using CURE's Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoi - GlobeNewswire
5/12/2022 12:00:00 AM2 years 11 months ago
by Cure Pharmaceutical Holding Corp.
by Cure Pharmaceutical Holding Corp.
CURE’s Patented and Proprietary OTF Vitamin D Found to be More Effective than Standard Supplementation in Achieving pre- and post-Surgery Vitamin D......
- CUREs Patented and Proprietary OTF Vitamin D Found to be More Effective than Standard Supplementation in Achieving pre- and post-Surgery Vitamin D Sufficiency Necessary to Reduce Immune-Media… [+6505 chars] full article...